Cargando…
Thoracic Radiotherapy in Limited-Stage SCLC—a Population-Based Study of Patterns of Care in Norway From 2000 Until 2018
INTRODUCTION: Twice-daily (BID) thoracic radiotherapy (TRT) of 45 Gy per 30 fractions is recommended for limited-stage (LS) SCLC, but most patients are treated with once-daily (OD) schedules owing to toxicity concerns and logistic challenges. An alternative is hypofractionated OD TRT of 40 to 42 Gy...
Autores principales: | Graabak, Gustav, Grønberg, Bjørn Henning, Sandvei, Marie Søfteland, Nilssen, Yngvar, Halvorsen, Tarje Onsøien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801751/ https://www.ncbi.nlm.nih.gov/pubmed/35146461 http://dx.doi.org/10.1016/j.jtocrr.2021.100270 |
Ejemplares similares
-
Associations between Measured and Patient-Reported Physical Function and Survival in Advanced NSCLC
por: Stokke, Kristin, et al.
Publicado: (2022) -
Prognostic Value of Post First-Line Chemotherapy Glasgow Prognostic
Score in Advanced Non-Small Cell Lung Cancer
por: Stokke, Kristin, et al.
Publicado: (2022) -
Associations between muscle measures, survival, and toxicity in patients with limited stage small cell lung cancer
por: Halvorsen, Tarje Onsøien, et al.
Publicado: (2020) -
Associations between detectable circulating tumor DNA and tumor glucose uptake measured by (18)F-FDG PET/CT in early-stage non-small cell lung cancer
por: Ottestad, Anine Larsen, et al.
Publicado: (2023) -
Correction: Associations between detectable circulating tumor DNA and tumor glucose uptake measured by (18)F-FDG PET/CT in early-stage non-small cell lung cancer
por: Ottestad, Anine Larsen, et al.
Publicado: (2023)